Polymorphisms in gene MTHFR modify the association between gestational weight gain and adverse birth outcomes

Weixiang Wu, Dan Luo, Xiaolin Ruan, Chunming Gu, Weiming Lü, Kailing Lian, Xiaoping MuFrontiers in Nutrition 2022 · DOI

TL;DR

This study demonstrates that maternal genetic variations in the MTHFR gene—specifically the A1298C polymorphism—act as a significant modifier in the relationship between gestational weight gain (GWG) and birth outcomes. While excessive or insufficient weight gain generally predicts adverse outcomes like macrosomia or low birth weight, these risks are dramatically amplified in women carrying the MTHFR A1298C AA genotype.

What Problem Does This Paper Address?

It is well-established that how much weight a woman gains during pregnancy (Gestational Weight Gain, or GWG) is a strong predictor of the baby’s health. Gain too much, and the risk of macrosomia (a very large baby) or "large-for-gestational age" (LGA) increases. Gain too little, and the risk of "small-for-gestational age" (SGA) or low birth weight (LBW) goes up.

However, clinical reality is messy: some women gain very little weight and have perfectly healthy babies, while others follow the guidelines and still face complications. This suggests a "missing link"—likely maternal genetics. The researchers focused on the MTHFR gene, which codes for an enzyme critical to folate metabolism and homocysteine levels. Since these pathways are vital for DNA methylation and lipid metabolism, the authors hypothesized that MTHFR variants might change how a mother's body processes weight gain into fetal growth.

Methods

The researchers conducted a retrospective cohort study involving 2,967 Chinese pregnant women at a tertiary hospital in Guangzhou.

  1. Categorization: Women were divided into "insufficient," "sufficient," and "excessive" GWG groups based on the Institute of Medicine (IOM) criteria.
  2. Genotyping: They used PCR to identify two common single nucleotide polymorphisms (SNPs) in the MTHFR gene: C677T and A1298C.
  3. Statistical Modeling: Multivariable logistic regression models were used to calculate Odds Ratios (ORs) for adverse outcomes (LBW, macrosomia, SGA, LGA). Crucially, they adjusted for confounders like maternal age, education, parity, and pregnancy complications (GDM/HDP).
  4. Interaction Analysis: They performed stratified analyses to see if the impact of GWG differed depending on which genetic variant the mother carried.

Datasets

The study utilized a clinical dataset of 2,967 mother-infant pairs from the Guangdong Women and Children Hospital (2017–2019). This is a specific Han Chinese population. The researchers compared their findings against both the IOM standards and WHO BMI classifications to ensure the robustness of their results.

Key Insights and Ideas

  • Genetics as a Risk Modifier: The most striking insight is that the "standard" risks associated with weight gain aren't universal. The association between GWG and adverse outcomes like LBW and macrosomia was primarily significant only among women with the A1298C AA genotype.
  • The "Double Hit" of Insufficient Gain: For women who gained less weight than recommended, those with the AA genotype faced a nearly four-fold increase in the risk of having a low-birth-weight baby compared to those with the AC or CC genotypes.
  • The Folate-Homocysteine Connection: The paper suggests that MTHFR polymorphisms might impair the body's ability to manage fat storage and nutrient transfer to the fetus via epigenetic mechanisms (DNA methylation), effectively making the fetus more sensitive to the mother's nutritional status.

Key Results

  • General GWG Trends: Across the whole group, excessive GWG increased the odds of macrosomia (OR = 3.47) and LGA (OR = 3.25), while insufficient GWG increased the odds of SGA (OR = 1.68).
  • Genotype-Specific Risk: Among women with insufficient GWG, the risk of Low Birth Weight (LBW) was significantly higher in the A1298C AA genotype group (OR = 3.96, 95% CI: 1.57–10.01) compared to the AC+CC group.
  • The C677T Variant: Interestingly, while the C677T variant is often the "famous" MTHFR mutation, this study found that the A1298C variant was the primary modifier of the GWG-birth weight relationship in this population.

Limitations and Future Work

  • Retrospective Design: As a retrospective study, it can show associations but cannot strictly prove that the gene caused the outcome.
  • Self-Reported Data: Pre-pregnancy BMI was based on self-reported weight, which is prone to recall bias.
  • Population Specificity: The study was limited to a Han Chinese population. Because allele frequencies vary significantly across ethnicities, these results might not be directly applicable to other groups.
  • Unmeasured Confounders: The authors note they did not have data on maternal diet (specifically folate intake) or physical activity, both of which interact heavily with the MTHFR pathway.
  • Future Directions: The authors suggest future prospective studies should look at a wider range of SNPs across the entire MTHFR gene and include more diverse ethnic cohorts to see if this "genetic volume knob" effect holds globally.

Summary updated

Abstract

Evidence suggests a potential relationship between gestational weight gain (GWG) and adverse birth outcomes. However, the role of maternal genetic polymorphisms remains unclear. This study was conducted to investigate whether the relationship of GWG with risk of adverse birth outcomes was modified by methylenetetrahydrofolate reductase (<i>MTHFR</i>) polymorphisms. A total of 2,967 Chinese pregnant women were included and divided into insufficient, sufficient, and excessive groups based on the Institute of Medicine (IOM) criteria. Polymorphisms of C677T and A1298C in gene <i>MTHFR</i> were genotyped. Multivariable logistic regression models were introduced after controlling major confounders. Excessive GWG was found to increase the odds ratio (OR) for macrosomia [OR = 3.47, 95% confidence interval (CI): 1.86-6.48] and large-for-gestational age (LGA, OR = 3.25, 95% CI: 2.23-4.74), and decreased the OR for small-for-gestational age (SGA, OR = 0.60, 95% CI: 0.45-0.79). Pregnant women with insufficient GWG had a higher frequency of SGA (OR = 1.68, 95% CI: 1.32-2.13) and a lower rate of LGA (OR = 0.51, 95% CI: 0.27-0.96). Interestingly, significant associations of GWG categories in relation to low birth weight (LBW), macrosomia, and SGA were only suggested among pregnant women with <i>MTHFR</i> A1298C AA genotype. Among pregnant women with insufficient GWG group, an increased risk of 3.96 (95% CI: 1.57-10.01) for LBW was observed among subjects with the A1298C AA genotype, compared to the AC+CC genotype group. GWG categories are closely related to LBW, macrosomia, SGA and LGA, and the associations were modified by the polymorphism of <i>MTHFR</i> A1298C.
BibTeX
@inproceedings{wu2022polymorphisms,
  author = {Weixiang Wu and Dan Luo and Xiaolin Ruan and Chunming Gu and Weiming Lü and Kailing Lian and Xiaoping Mu},
  title = {{Polymorphisms in gene MTHFR modify the association between gestational weight gain and adverse birth outcomes}},
  booktitle = {Frontiers in Nutrition},
  year = {2022},
  doi = {10.3389/fnut.2022.919651},
}
Figure